The FTY720 story

Therapeutic Drug Monitoring

Volumn 22, Issue 1, 2000, Pages 47-51

  Napoli, Kimberly L ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Drug; Immunosuppressant; Immunosuppressive; Transplantation

Indexed keywords

CYCLOSPORIN; FINGOLIMOD; IMMUNOSUPPRESSIVE AGENT; SERINE PALMITOYLTRANSFERASE; THERMOZYMOCIDIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHEMICAL STRUCTURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG SYNTHESIS; DRUG TOLERABILITY; ENZYME BINDING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RAT;

ANIMALS; CLINICAL TRIALS; DRUG COMBINATIONS; FATTY ACIDS, MONOUNSATURATED; GRAFT REJECTION; HUMANS; IMMUNITY, CELLULAR; IMMUNOSUPPRESSIVE AGENTS; PROPYLENE GLYCOLS; SPHINGOSINE;

EID: 0033965398     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200002000-00010     Document Type: Article

References (21)

1. Fujita T, Inoue K, Yamamoto S, et al. Fungal metabolites. Part II. A potent immunosuppressive activity found in Iscarii sinclairii metabolite. J Antibiot 1994;47:208-15.
2. Kluepfel D, Bagli J, Baker H, Charest M-P, Kudelski A, Sehgal N, Vézina C. Myriocin, a new antifungal antibiotic from Myrioccum albomyces. J Antibiot 1972;25:109-15.
3. Bagli JF, Kluepfel D, St-Jacques M. Elucidation of structure and stereochemistry of myriocin. A novel antifungal antibiotic. J Org Chem 1973;38:1253-60.
4. Aragozzini F, Manachini PL, Craveri R, Rindone B, Scolastico C. Isolation and structure determination of a new antifungal (-hydroxymethyl-(-amino acid. Tetrahedron 1972;28:5493-8.
5. Miyake Y, Kozutsumi Y, Nakamura S, Fujita T, Kawasaki T. Serine palmitoyltransferase is the primary target of a sphingosinelike immunosuppressant, ISP-1/myriocin. Biochem Biophys Res Comm 1995;211:396-403.
6. Chiba K, Hoshino Y, Fujita T. Isolation of cytotoxic T lymphocytes induction by Iscaria sinclairii-derived immunosuppressant, ISP-1. Saibou 1992;24:212-6.
7. Fujita T, Yoneta M, Hirose R, et al. Simple compounds, 2-alkyl-2-amino-1,3-propanedioIs have potent immunosuppressive activity. Bioorg & Med Chem Lett 1994;5:847-52.
8. Adachi K, Kohara T, Nakao N, et al. Design, synthesis, and structure-activity relationships of 2-substituted-2-amino-1,3-propanediols: Discovery of a novel immunosuppressant, FTY720. Bioorg & Med Chem Lett 1995;5:853-6.
9. Fujita T, Hirose R, Yoneta M, et al. Potent immunosuppressants, 2-alkly-2-aminopropane-1,3-diols. J Med Chem 1996;39:4451-9.
10. Suzuki S, Enosawa S, Kakefuda T, et al. A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation. Transplantation 1996;61:200-5.
11. Chiba K, Hoshino Y, Suzuki C, et al. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats. Transplant Proc 1996;28:1056-9.
12. Suzuki S, Li X-K, Enosawa S, Shinomiya T. A new immunosuppressant, FTY720, induces bcl-2-associated apoptotic cell death in human lymphocytes. J Immunol 1996;89:518-23.
13. Chiba K, Yanagawa Y, Masubuchi Y, Kataoka H, Kawaguchi T, Ohtsuki M, Hoshino Y. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J Immunol 1998;160:5037-44.
14. Yanagawa Y, Sugahara K, Kataoka H, Kawaguchi T, Masubuchi Y, Chiba K. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo. J Immunol 1998;160:5493-9.
15. Luo Z-J, Tanaka T, Kimura F, Miyasaka M. Analysis of the mode of action of a novel immunosuppressant FTY720 in mice. Immunopharmacology 1999;41:199-207.
16. Hoshino Y, Suzuki C, Ohtsuki M, Masubuchi Y, Amano Y, Chiba K. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A. Transplant Proc 1996;28:1060-1.
17. Kawaguchi T, Hoshino Y, Rahman F, et al. FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A. Transplant Proc 1996;28:1062-3.
18. Troncoso P, Stepkowski SM, Wang M-E, Qu X, Chueh S-C, Clark J, Kahan BD. Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine. Transplantation 1999;67:145-51.
19. Kahan BD. FTY720: a new immunosuppressive agent with novel mechanism(s) of action. Transplant Proc 1998;30:2210-3.
20. Brunkhorst R, Neumeyer H, Hiss, et al. Human safety and pharmacology of FTY720. Abstract 585 presented at: Annual Meeting of the American Society of Transplantation; May 17-19, 1999; Chicago, IL.
21. Neumeyer, Brunkhorst R, Budde K, et al. Human pharmacokinetics of FTY720. Abstract 791 presented at: Annual Meeting of the American Society of Transplantation; May 17-19, 1999; Chicago, IL.